Mycophyto
Active#15 worldwide · Biological inputsSelects and mass-produces mycorrhizal fungi and associated microbes as biostimulants for vineyards, vegetables and field crops, helping plants retain water and absorb nutrients.
Uback rankings
How the AI ranks →| Ranking | Tier | Rank | Edition | Next update |
|---|---|---|---|---|
| Biological inputs · worldwide | Top 32 | #15 | Edition 0 · Oct 2026 | 12 Feb 2027 |
Estimated valuation
AI · Biological inputs ranking (worldwide)- Anchor
- Last known equity round: Series A · USD 18.7M · Jan 2026
An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method
Funding history
| Date | Round | Amount | Type | Investors |
|---|---|---|---|---|
| Jan 2026 | Series A | USD 18.7M | Equity | Innovacom, BNP Paribas, Bpifrance Deep Tech 2030, CDG Invest, Noshaq, RSI, Crédit Agricole |
EUR 16M.
Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.
Independent analyses
By industry professionals & analystsIndustry professionals and financial analysts can publish their own analysis of Mycophyto as a PDF. It must answer at least one of these four questions, and stick to them:
Analyses are the opinion of their authors, not of Uback. They are checked before publication.
Comparable companies in biological inputs
Full biological inputs ranking →Investors in Mycophyto: Innovacom · BNP Paribas · Bpifrance Deep Tech 2030 · CDG Invest · Noshaq · RSI · Crédit Agricole
Last updated: Oct 2026Report an error
Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.